FluoroPharma Medical Inc FPMI
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.00
- Day Range
- $0.00–0.00
- 52-Week Range
- $0.00–0.00
- Bid/Ask
- $0.00 / $0.02
- Market Cap
- $3,426.23
- Volume/Avg
- 44,700 / 30,365
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
FluoroPharma Medical Inc is a US-based biopharmaceutical company. It specializes in developing and commercializing molecular imaging pharmaceuticals with initial applications in the area of cardiology. The company focuses on the development of novel cardiovascular imaging agents which detect and assess acute and chronic forms of coronary artery disease (CAD). The company’s clinical-stage molecular imaging pharmaceutical product candidates are 18-F TPP (BFPET) and 18-F FCPHA (CardioPET). The 18-F TPP is designed for use in stress-testing for patients with proven CAD whereas 18-F FCPHA is a molecular imaging agent which is designed to assess myocardial blood flow and metabolism in patients with CAD. The company operates in a single segment being Biopharmaceutical research and development.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Core
- Total Number of Employees
- 4
- Website
- http://www.fluoropharma.com
Valuation
|
Metric
|
FPMI
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
FPMI
|
|---|---|
Quick Ratio | 0.00 |
Current Ratio | 0.00 |
Interest Coverage | −0.62 |
Quick Ratio
FPMI
Profitability
|
Metric
|
FPMI
|
|---|---|
Return on Assets (Normalized) | −610.54% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
FPMI
Biotechnology Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
NVO
| Novo Nordisk A/S ADR | Sywpftcm | Tqr | $554.7 Bil | |
VRTX
| Vertex Pharmaceuticals Inc | Cbndrcksw | Rnqbxtq | $103.6 Bil | |
REGN
| Regeneron Pharmaceuticals Inc | Vfxjldpx | Fhzqtv | $97.8 Bil | |
MRNA
| Moderna Inc | Hwqqpvk | Dxhl | $38.8 Bil | |
ARGX
| argenx SE ADR | Pwjbfcn | Xycg | $22.0 Bil | |
BNTX
| BioNTech SE ADR | Rtwkwjky | Dgckw | $21.2 Bil | |
ALNY
| Alnylam Pharmaceuticals Inc | Mvgpkbbr | Yyqjdnm | $18.2 Bil | |
BMRN
| Biomarin Pharmaceutical Inc | Rkxrxmxd | Ckbtnn | $17.3 Bil | |
RPRX
| Royalty Pharma PLC Class A | Yzxmnwmxg | Wmvvb | $12.5 Bil | |
INCY
| Incyte Corp | Lpqngmzt | Ktlxzl | $11.5 Bil |